Pharma & Biotech

Gene therapy specialist Ocugen delivered a brutal shock to investors this week, with its shares plummeting amid growing concerns about...

Pharmaceutical leader Eli Lilly is making strategic moves on multiple fronts, with a massive investment initiative in India coinciding with...

Valneva shares are experiencing extreme volatility as the biotech firm navigates conflicting developments. While a major refinancing deal has resolved...

The Dutch e-pharmacy pioneer Redcare Pharmacy has demonstrated a remarkable turnaround, with its shares surging following months of downward pressure....

BioNTech has reached a significant milestone in its return to cancer research, announcing positive results from a pivotal Phase 3...

Viking Therapeutics shares continue to face significant downward momentum amid persistent selling activity. Despite the company's advanced clinical development programs,...

Eli Lilly and Company has achieved two significant regulatory approvals that promise to accelerate the pharmaceutical giant's expansion within its...

The biotechnology sector offers little mercy to struggling companies, and Ocugen finds itself in precisely that position. With investor confidence...

Innoviva shares are approaching a critical juncture, with two significant near-term events poised to shape the biopharmaceutical company's trajectory. Despite...

After a prolonged period of underwhelming performance, Arcturus Therapeutics has staged a remarkable market recovery. The biotech firm's shares experienced...